September 4, 2025 · Form 4 insider transaction
Moat Ross sold 3,523 shares of Kiniksa Pharmaceuticals Ltd. at $35.31 per share, a transaction worth $124.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.